Molecular Pharmaceutics
[ASAP] Reproductive Toxicity Evaluation of Graphene-Based Tumor Cell Nucleus-Targeting Fluorescent Nanoprobes on Reproduction and Offspring Health
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00934
Molecular Pharmaceutics
[ASAP] Development of Cationic Lipid LAH4-L1 siRNA Complexes for Focused Ultrasound Enhanced Tumor Uptake
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00909
Molecular Pharmaceutics
[ASAP] Gene Reprogramming Armed Macrophage Membrane-Camouflaged Nanoplatform Enhances Bionic Targeted Drug Delivery to Solid Tumor for Synergistic Therapy
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00929
Molecular Pharmaceutics
[ASAP] Combining β‑Carotene with 5‑FU via Polymeric Nanoparticles as a Novel Therapeutic Strategy to Overcome uL3-Mediated Chemoresistance in p53-Deleted Colorectal Cancer Cells
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00876
Molecular Pharmaceutics
[ASAP] Diffusion and Flux Improvement of Drugs through Complexation
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c00159
Molecular Pharmaceutics
[ASAP] Enhancement of the Oral Availability of Cabazitaxel Using the Cytochrome P450 3A (CYP3A) Inhibitor Ritonavir in Mice
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c01076
Molecular Pharmaceutics
[ASAP] Investigating Key Molecular Descriptors Affecting Particle Size: A Predictive Exemplary Approach for Self-Emulsifying System
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c01118
Molecular Pharmaceutics
[ASAP] Voices in <italic toggle=”yes”>Molecular Pharmaceutics</italic>: Meet Dr. Muling Zeng, Who Nanosizes Traditional Chinese Medicines and Natural Products for Unique Applications
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c00228
Molecular Pharmaceutics
[ASAP] Injectable Anhydrous Poly(ethylene glycol) Polymer Liquids Form Protein Depot for Extended Controlled Release Applications Via Rapid In Situ Gelation
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c01060
Molecular Pharmaceutics
[ASAP] Investigating Generation of Antibodies against the Lipid Nanoparticle Vector Following COVID-19 Vaccination with an mRNA Vaccine
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c01036